Abstract
The U.S. Office of Human Research Protection (OHRP) has just issued draft guidance on the elements of informed consent it will require when research is conducted to evaluate treatment options within the current standard of care. The draft guidance (available at www.hhs.gov/ohrp/newsroom/rfc/comstdofcare.html) is open for public comment until December 23, 2014.